http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102671186-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_338122610c66aec3edaa563d6ecc7b71 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate | 2011-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11053b80864ba8df7f72375496661db0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0408e78c28dcb8ea8e9d6a16c600bdb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b86dbecdc6daa6998157a9f0664a335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2877a5d0db04754a6a5642814406488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8630098f3edf692d3fd2302e603ea061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0708c420116f92222190229ce6c0b34 |
| publicationDate | 2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102671186-B |
| titleOfInvention | Hematopoiesis-promoting medicine combination and application thereof |
| abstract | The purpose of the invention is to provide a hematopoiesis-promoting medicine combination and application thereof. The medicine combination contains the cytokine LIGHT; the invention successfully applies the cytokine LIGHT to promote in vivo hematopoiesis, thus providing the new application of the cytokine LIGHT, the cytokine LIGHT can be used for developing a novel cytokine and the medicine which not only can promote hematopoiesis but also can inhibit tumor cell proliferation, the hematopoiesis-promoting medicine combination is significant in promoting the recovery of the hematopoietic function of patients receiving clinical tumor chemoradiotherapy, increasing the tumor-curing rate and decreasing the infection incidence, the tumor recurrence rate and the death rate, and thereby the purpose of the invention is achieved. |
| priorityDate | 2011-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.